A detailed history of Perigon Wealth Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 80,697 shares of MRK stock, worth $8.07 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
80,697
Previous 103,961 22.38%
Holding current value
$8.07 Million
Previous $12.9 Million 28.8%
% of portfolio
0.25%
Previous 0.38%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$111.15 - $128.97 $2.59 Million - $3 Million
-23,264 Reduced 22.38%
80,697 $9.16 Million
Q2 2024

Aug 02, 2024

SELL
$123.8 - $132.96 $7.17 Million - $7.7 Million
-57,935 Reduced 35.79%
103,961 $12.9 Million
Q1 2024

Apr 29, 2024

BUY
$113.24 - $131.95 $215,835 - $251,496
1,906 Added 1.19%
161,896 $21.4 Million
Q4 2023

Jan 29, 2024

BUY
$100.18 - $109.02 $4.48 Million - $4.88 Million
44,738 Added 38.82%
159,990 $17.4 Million
Q3 2023

Oct 30, 2023

BUY
$102.95 - $114.33 $152,160 - $168,979
1,478 Added 1.3%
115,252 $11.9 Million
Q2 2023

Aug 02, 2023

BUY
$108.61 - $118.38 $6 Million - $6.54 Million
55,228 Added 94.33%
113,774 $13.1 Million
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $5.49 Million - $6.12 Million
-53,304 Reduced 47.66%
58,546 $6.23 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $1.54 Million - $1.97 Million
17,555 Added 18.62%
111,850 $12.4 Million
Q3 2022

Dec 13, 2022

BUY
$84.53 - $94.96 $108,367 - $121,738
1,282 Added 1.38%
94,295 $8.12 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $568,399 - $644,309
6,808 Added 7.9%
93,013 $8.48 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $101,443 - $113,712
1,380 Added 1.63%
86,205 $7.07 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $127,646 - $159,893
-1,766 Reduced 2.04%
84,825 $6.5 Million
Q3 2021

Nov 01, 2021

BUY
$71.68 - $78.83 $6.21 Million - $6.83 Million
86,591 New
86,591 $6.5 Million
Q3 2021

Oct 25, 2021

SELL
$71.68 - $78.83 $6.38 Million - $7.02 Million
-89,006 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$70.31 - $77.77 $786,136 - $869,546
-11,181 Reduced 11.16%
89,006 $6.92 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $716,694 - $844,192
-10,408 Reduced 9.41%
100,187 $7.72 Million
Q4 2020

Jan 28, 2021

BUY
$71.77 - $79.65 $244,161 - $270,969
3,402 Added 3.17%
110,595 $9.05 Million
Q3 2020

Nov 03, 2020

SELL
$73.18 - $82.95 $198,537 - $225,043
-2,713 Reduced 2.47%
107,193 $8.89 Million
Q2 2020

Jul 29, 2020

BUY
$70.42 - $80.13 $1.08 Million - $1.23 Million
15,317 Added 16.19%
109,906 $8.5 Million
Q1 2020

Apr 17, 2020

SELL
$63.36 - $87.82 $194,832 - $270,046
-3,075 Reduced 3.15%
94,589 $7.8 Million
Q4 2019

Jan 13, 2020

SELL
$77.58 - $87.54 $1.09 Million - $1.23 Million
-14,087 Reduced 12.61%
97,664 $8.95 Million
Q3 2019

Oct 25, 2019

BUY
$76.08 - $82.93 $133,444 - $145,459
1,754 Added 1.59%
111,751 $9.5 Million
Q2 2019

Aug 05, 2019

SELL
$69.84 - $81.59 $210,008 - $245,341
-3,007 Reduced 2.66%
109,997 $9.22 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $1.03 Million - $1.18 Million
-14,817 Reduced 11.59%
113,004 $8.63 Million
Q4 2018

Feb 11, 2019

BUY
$65.24 - $75.71 $610,581 - $708,569
9,359 Added 7.9%
127,821 $9.2 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $63,689 - $74,895
1,104 Added 0.94%
118,462 $8.46 Million
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $69,992 - $82,234
1,377 Added 1.19%
117,358 $7.18 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $10,192 - $11,846
-200 Reduced 0.17%
115,981 $6.37 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $142,729 - $170,434
-2,765 Reduced 2.32%
116,181 $6.6 Million
Q3 2017

Dec 05, 2017

SELL
$58.67 - $63.13 $91,877 - $98,861
-1,566 Reduced 1.3%
118,946 $7.67 Million
Q2 2017

Sep 12, 2017

BUY
N/A
120,512 New
120,512 $7.78 Million
Q3 2011

Nov 14, 2022

BUY
N/A
1,282
94,295 $8.12 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.